Application of extracorporeal membrane oxygenation in high-risk percutaneous coronary intervention without obvious shock
-
摘要:
经皮冠状动脉介入治疗(PCI)对于不适合手术或拒绝手术的高危冠状动脉疾病患者而言，是一种可行的血管重建策略。然而，该类高危患者在球囊充气或复杂操作过程中，存在较高的血流动力学崩溃风险，特别是当冠状动脉夹层伴血管闭合或无复流发生时。静脉-动脉体外膜肺氧合(VA-ECMO)作为一种临时机械循环支持(MCS)技术已被引入高危PCI，其在手术过程中可提供充分的全身灌注。本文就体外膜肺氧合(ECMO)预防性用于技术复杂的无明显休克的高危PCI相关研究进展进行综述。
-
关键词:
- 体外膜肺氧合 /
- 经皮冠状动脉介入治疗 /
- 机械循环支持 /
- 血流动力学 /
- 休克
Abstract:Percutaneous coronary intervention (PCI) is a feasible strategy for vascular remodeling in high-risk coronary artery disease patients who are not suitable for surgery or refuse surgery. However, such high-risk patients are at higher risk of hemodynamic collapse during balloon inflating or complex procedures, especially when coronary artery dissection with vessel closure or without re-flow occurs. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been introduced as a temporary mechanical circulatory support (MCS)for high-risk PCI, which can provide adequate systemic perfusion during surgery. This article reviewed the studies on the preventive use of extra-corporeal membrane oxygenation (ECMO) in technically complex high-risk PCI without obvious shock.
-
-
[1] NEUMANN F J, SOUSA-UVA M, AHLSSON A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165. doi: 10.1093/eurheartj/ehy394
[2] THUIJS D J F M, KAPPETEIN A P, SERRUYS P W, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentrerandomised controlled SYNTAX trial[J]. Lancet, 2019, 394(10206): 1325-1334. doi: 10.1016/S0140-6736(19)31997-X
[3] WALDO S W, SECEMSKY E A, O'BRIEN C, et al. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention[J]. Circulation, 2014, 130(25): 2295-2301. doi: 10.1161/CIRCULATIONAHA.114.011541
[4] BOUKHRIS M, AZZARELLI S, TOMASELLO S D, et al. Diabetic patient with three-vessel disease and left main involvement. Surgery yes, but not always[J]. Egypt Heart J, 2015, 67(1): 83-87. doi: 10.1016/j.ehj.2014.11.004
[5] AGGARWAL B, AMAN W, JEROUDI O, et al. Mechanical circulatory support in high-risk percutaneous coronary intervention[J]. Methodist Debakey Cardiovasc J, 2018, 14(1): 23-31. doi: 10.14797/mdcj-14-1-23
[6] HUANG C C, HSU J C, WU Y W, et al. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock[J]. Int J Cardiol, 2018, 269: 45-50. doi: 10.1016/j.ijcard.2018.07.023
[7] CHUNG S Y, TONG M S, SHEU J J, et al. Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention[J]. Int J Cardiol, 2016, 223: 412-417. doi: 10.1016/j.ijcard.2016.08.068
[8] 韩宗茂, 高洁, 高传玉, 等. 早期血运重建及体外膜肺氧合支持治疗急性心肌梗死合并心原性休克的疗效观察及影响因素分析[J]. 中国循环杂志, 2021, 36(5): 433-438. doi: 10.3969/j.issn.1000-3614.2021.05.004 [9] RIHAL C S, NAIDU S S, GIVERTZ M M, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American heart assocation, the cardiological society of India, and sociedad Latino Americana de cardiologiaintervencion; affirmation of value by the Canadian association of interventional cardiology-association canadienne de cardiologie d'intervention[J]. J Am Coll Cardiol, 2015, 65(19): e7-e26. doi: 10.1016/j.jacc.2015.03.036
[10] THIELE H, ZEYMER U, NEUMANN F J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med, 2012, 367(14): 1287-1296. doi: 10.1056/NEJMoa1208410
[11] O'NEILL W W, KLEIMAN N S, MOSES J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2. 5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT Ⅱ study[J]. Circulation, 2012, 126(14): 1717-1727. doi: 10.1161/CIRCULATIONAHA.112.098194
[12] PERERA D, STABLES R, CLAYTON T, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention[J]. Circulation, 2013, 127(2): 207-212. doi: 10.1161/CIRCULATIONAHA.112.132209
[13] BURZOTTA F, RUSSO G, BASILE E, et al. How to choose between intra-aortic balloon pump, Impella and extracorporeal membrane oxygenation[J]. G Ital Cardiol (Rome), 2018, 19(6 Suppl 1): 5S-13S.
[14] 韩雅玲. 中国经皮冠状动脉介入治疗指南2012(简本)[J]. 中华危重症医学杂志: 电子版, 2012, 5(3): 169-180. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWZD201203006.htm [15] TEIRSTEIN P S, VOGEL R A, DORROS G, et al. Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal coronary angioplasty[J]. J Am Coll Cardiol, 1993, 21(3): 590-596. doi: 10.1016/0735-1097(93)90089-J
[16] TAUB J O, L'HOMMEDIEU B D, RAITHEL S C, et al. Extracorporeal membrane oxygenation for percutaneous coronary angioplasty in high risk patients[J]. ASAIO Trans, 1989, 35(3): 664-666. doi: 10.1097/00002216-198907000-00161
[17] SHAMMAS N W, ROBERTS S, EARLY G. Extracorporeal membrane oxygenation for unprotected left main stenting in a patient with totally occluded right coronary artery and severe left ventricular dysfunction[J]. J Invasive Cardiol, 2002, 14(12): 756-759.
[18] VAINER J, VAN OMMEN V, MAESSEN J, et al. Elective high-risk percutaneous coronary interventions supported by extracorporeal life support[J]. Am J Cardiol, 2007, 99(6): 771-773. doi: 10.1016/j.amjcard.2006.10.034
[19] GALASSI A R, GANYUKOV V, TOMASELLO S D, et al. Successful antegrade revascularization by the innovation of composite core dual coil in a three-vessel total occlusive disease for cardiac arrest patient using extracorporeal membrane oxygenation[J]. Eur Heart J, 2014, 35(30): 2009. doi: 10.1093/eurheartj/ehu070
[20] KASS M, MOON M, VO M, et al. Awake extracorporeal membrane oxygenation for very high-risk coronary angioplasty[J]. Can J Cardiol, 2015, 31(2): 227. e11-227. e13. doi: 10.1016/j.cjca.2014.11.004
[21] TOMASELLO S D, BOUKHRIS M, GANYUKOV V, et al. Outcome of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: a single-center experience[J]. Heart Lung, 2015, 44(4): 309-313. doi: 10.1016/j.hrtlng.2015.03.005
[22] SHAUKAT A, HRYNIEWICZ-CZENESZEW K, SUN B, et al. Outcomes of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: a single-center experience and review of the literature[J]. J Invasive Cardiol, 2018, 30(12): 456-460.
[23] BRSCIC E, ROVERO G, TESTA K, et al. In-hospital and mid-term outcomes of ECMO support during coronary, structural, or combined percutaneous cardiac intervention in high-risk patients - A single-center experience[J]. Cardiovasc Revasc Med, 2021, 32: 63-67. doi: 10.1016/j.carrev.2020.12.020
[24] VAN DEN BRINK F S, MEIJERS T A, HOFMA S H, et al. Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention[J]. Neth Heart J, 2020, 28(3): 139-144. doi: 10.1007/s12471-019-01350-8
[25] LI Y N, YAN S J, GAO S Z, et al. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis[J]. Eur J Cardiothorac Surg, 2019, 55(3): 395-404. doi: 10.1093/ejcts/ezy304
[26] VALLABHAJOSYULA S, O'HORO J C, ANTHARAM P, et al. Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock[J]. ASAIO J, 2020, 66(5): 497-503. doi: 10.1097/MAT.0000000000001039
[27] TRUBY L K, TAKEDA K, MAURO C, et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support[J]. ASAIO J, 2017, 63(3): 257-265. doi: 10.1097/MAT.0000000000000553
[28] ORTUNO S, DELMAS C, DIEHL J L, et al. Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use[J]. Ann Cardiothorac Surg, 2019, 8(1): E1-E8. doi: 10.21037/acs.2018.08.05
[29] 高国栋, 龙村, 胡强, 等. 体外膜肺氧合支持治疗期间机体凝血功能的动态变化[J]. 实用临床医药杂志, 2015, 19(9): 9-11, 17. doi: 10.7619/jcmp.201509003 [30] MCCARTHY F H, MCDERMOTT K M, SPRAGAN D, et al. Unconventional volume-outcome associations in adult extracorporeal membrane oxygenation in the United States[J]. Ann Thorac Surg, 2016, 102(2): 489-495. doi: 10.1016/j.athoracsur.2016.02.009
[31] AISSAOUI N, EL-BANAYOSY A, COMBES A. How to wean a patient from veno-arterial extracorporeal membrane oxygenation[J]. Intensive Care Med, 2015, 41(5): 902-905. doi: 10.1007/s00134-015-3663-y
-
期刊类型引用(20)
1. 管婉如. 酮咯酸氨丁三醇不同给药途径治疗四肢骨折的疗效对比研究. 当代医学. 2021(03): 162-163 . 
百度学术
2. 张丹丹，梁小余. 临床护理路径对四肢骨折患者疼痛程度及并发症的影响. 航空航天医学杂志. 2021(04): 505-506 . 百度学术
3. 郭喜桃. 疼痛护理对四肢骨折患者术后疼痛影响的研究. 中外医疗. 2021(25): 137-139+143 . 百度学术
4. 刘芝静. 系统规范化护理在股骨干骨折术后应用自控镇痛泵患者中的干预效果. 医疗装备. 2020(14): 164-165 . 百度学术
5. 刘慧娟，李星星. 心理护理对骨科四肢骨折术后患者疼痛的价值体会. 黑龙江中医药. 2020(03): 277-278 . 百度学术
6. 梁杰. 手术室护理干预对开放性四肢骨折患者手术效果与并发症的影响. 中国医药指南. 2020(25): 169-170+173 . 百度学术
7. 黄丽君，帅品花，王璐瑶，王民政. “医护一体化”疼痛关爱病房管理模式在四肢骨折患者围术期的应用效果. 中国当代医药. 2019(01): 233-235 . 百度学术
8. 杨清亚，郝静. 系统化护理在骨外固定支架治疗四肢长管状骨骨折中的应用. 实用临床医药杂志. 2019(02): 110-111+115 . 本站查看
9. 王莉菲. 院外延续性护理对老年下肢骨折患者运动功能及生活质量的影响. 中国民康医学. 2019(01): 164-166 . 百度学术
10. 张娟. 骨科手术患者术后疼痛护理干预的临床效果. 心理月刊. 2019(03): 74 . 百度学术
11. 姜海燕. 疼痛护理干预在四肢骨折患者术后护理中的应用. 心理月刊. 2019(15): 112 . 百度学术
12. 薛维娜. 系统化护理在骨外固定支架治疗四肢长管状骨骨折患者中的应用价值分析. 中国现代药物应用. 2019(19): 209-210 . 百度学术
13. 齐丽霞. 骨折患者应用镇痛泵的临床护理分析. 中国医药指南. 2019(27): 389-390 . 百度学术
14. 刘会平. 系统护理干预结合自控镇痛泵在股骨干骨折切开复位内固定患者中的应用效果. 医疗装备. 2019(20): 183-184 . 百度学术
15. 王永艳，高敏. 综合护理对四肢骨折患者术后疼痛缓解的效果. 临床医学研究与实践. 2018(15): 166-167 . 百度学术
16. 鲍海燕. 疼痛护理对四肢骨折患者术后疼痛及心理弹性的影响. 临床医学研究与实践. 2018(15): 168-169 . 百度学术
17. 韩春娟，惠娜，梁兰萍. 四肢骨折患者采取综合护理对缓解术后疼痛的效果. 临床医学研究与实践. 2018(22): 191-192 . 百度学术
18. 王丽君. 妇科手术患者自控镇痛泵并发症针对性护理干预效果分析. 中外女性健康研究. 2018(08): 95-96 . 百度学术
19. 程红. 骨科术后病人应用镇痛泵的观察和护理. 世界最新医学信息文摘. 2018(A4): 327-328 . 百度学术
20. 周静. 综合护理在四肢创伤骨折术后疼痛护理中的应用观察. 中外女性健康研究. 2017(17): 119+121 . 百度学术
其他类型引用(0)
计量
- 文章访问数:
- HTML全文浏览量:
- PDF下载量:
- 被引次数: 20
下载:
苏公网安备 32100302010246号